SELLAS Life Sciences (SLS) Change in Acquisitions & Divestments (2013)
SELLAS Life Sciences (SLS) reported Change in Acquisitions & Divestments of $2.5 million for Q4 2013, up 209.46% quarter-over-quarter from $814000.0 in Q3 2013.
SELLAS Life Sciences (SLS) Change in Acquisitions & Divestments (2013) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q4 2013.
- Change in Acquisitions & Divestments for Q4 2013 came in at $2.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $3.3 million (changed 0.0% YoY), and the FY2013 annual result was $3.9 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments climbed to $2.5 million in Q4 2013 per SLS's latest filing, from $814000.0 in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $2.5 million in Q4 2013 and troughed at $814000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 2.52 Mn |
| Dec 31, 2013 | 2.52 Mn |
| Sep 30, 2013 | 814,000.00 |
| Sep 30, 2013 | 814,000.00 |